Certain diet and lifestyle may contribute to islet β-cells protection in type-2 diabetes via the modulation of cellular pi3k/akt pathway

Open Biochemistry Journal

Volumn 8, Issue , 2014, Pages 74-82

  Kitagishi, Yasuko ^a   Nakanishi, Atsuko ^a   Minami, Akari ^a   Asai, Yurina ^a   Yasui, Mai ^a   Iwaizako, Akiko ^a   Suzuki, Miho ^a   Ono, Yuna ^a   Ogura, Yasunori ^a   Matsuda, Satoru ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

AKT; GSK3 cell signaling; Islet cells; PI3K; Type 2 diabetes

Indexed keywords

BETA CATENIN; CASPASE 9; FATTY ACID BINDING PROTEIN 4; G PROTEIN COUPLED RECEPTOR; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN BAD; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P27; REACTIVE OXYGEN METABOLITE; TUBERIN;

APOPTOSIS; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; DIET; DISEASE COURSE; DOWN REGULATION; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INFLAMMATION; LIFESTYLE; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; UPREGULATION;

EID: 84928990697     PISSN: None     EISSN: 1874091X     Source Type: Journal    
DOI: 10.2174/1874091x01408010074     Document Type: Article

References (106)

1. [1] Besingi, W.; Johansson, A. Smoke-related DNA methylation changes in the etiology of human disease. Hum. Mol. Genet., 2014, 23(9), 2290-2297.
2. [2] Basu, S.; Glantz, S.; Bitton, A.; Millett, C. The effect of tobacco control measures during a period of rising cardiovascular disease risk in India: a mathematical model of myocardial infarction and stroke. PLoS Med., 2013, 10(7), e1001480.
3. [3] Klop, B.; Elte, J.W.; Cabezas, M.C. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients, 2013, 5(4), 1218-1240.
4. [4] Brooks-Worrell, B.; Narla, R.; Palmer, J.P. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes Metab., 2013, 15 Suppl 3, 137-140.
5. [5] Bernard, C.; Berthault, M.F.; Saulnier, C.; Ktorza, A. Neogenesis vs. apoptosis As main components of pancreatic beta cell ass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J., 1999, 13(10), 1195-1205.
6. [6] Srivastava, S.K.; Yadav, U.C.; Reddy, A.B.; Saxena, A.; Tammali, R.; Shoeb, M.; Ansari, N.H.; Bhatnagar, A.; Petrash, M.J.; Srivastava, S.; Ramana, K.V. Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. Chem. Biol. Interact., 2011, 191(1-3), 330-338.
7. [7] Lu, X.; Liu, J.; Cao, X.; Hou, X.; Wang, X.; Zhao, C.; Wang, Y.; Li, Y.; Seo, H.; Gao, B. Native low density lipoprotein induces pancreatic β cell apoptosis through generating excess reactive oxygen species. Lipids Health Dis., 2011, 10, 123.
8. [8] Kaminski, A.; Welters, H.J.; Kaminski, E.R.; Morgan, N.G. Human and rodent pancreatic beta-cells express IL-4 receptors and IL-4 protects against beta-cell apoptosis by activation of the PI3K and JAK/STAT pathways. Biosci. Rep., 2009, 30(3), 169-175.
9. [9] Nguyen, K.T.; Tajmir, P.; Lin, C.H.; Liadis, N.; Zhu, X.D.; Eweida, M.; Tolasa-Karaman, G.; Cai, F.; Wang, R.; Kitamura, T.; Belsham, D.D.; Wheeler, M.B.; Suzuki, A.; Mak, T.W.; Woo, M. Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol. Cell Biol., 2006, 26(12), 4511-4518.
10. [10] Bernal-Mizrachi, E.; Wen, W.; Stahlhut, S.; Welling, C.M.; Permutt, M.A. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest., 2001, 108(11), 1631-1638.
11. [11] Curnock, A.P.; Ward, S.G. Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signaling. J. Immunol. Methods, 2003, 273(1-2), 29-41.
12. [12] Hers, I.; Vincent, E.E.; Tavaré, J.M. Akt signalling in health and disease. Cell Signal, 2011, 23(10), 1515-1527.
13. [13] Chan, T.O.; Tsichlis, P.N. PDK2: a complex tail in one Akt. Sci. STKE, 2001, 2001(66), pe1.
14. [14] Johnson, S.E.; Shah, N.; Bajer, A.A.; LeBien, T.W. IL-7 activates the phosphatidylinositol 3-kinase/AKT pathway in normal human thymocytes but not normal human B cell precursors. J. Immunol., 2008, 180(12), 8109-8117.
15. [15] Kwiatkowski, D.J. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Cancer Biol. Ther., 2003, 2(5), 471-476.
16. [16] Gao, C.; Hölscher, C.; Liu, Y.; Li, L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev. Neurosci., 2011, 23(1), 1-11.
17. [17] Koh, P.O. Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation. Neurosci. Lett., 2013, 555, 7-11.
18. [18] Robinson, K.A.; Buse, M.G. Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation. Am. J. Physiol. Endocrinol. Metab., 2008, 294(5), E870-E881.
19. [19] Tremblay, F.; Lavigne, C.; Jacques, H.; Marette, A. Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes, 2003, 52(1), 29-37.
20. [20] Chiu, T.T.; Sun, Y.; Koshkina, A.; Klip, A. Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance. J. Biol. Chem., 2013, 288(24), 17520-17531.
21. [21] Cherla, R.P.; Lee, S.Y.; Mulder, R.A.; Lee, M.S.; Tesh, V.L. Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Infect. Immun., 2009, 77(9), 3919-3931.
22. [22] Song, M.S.; Salmena, L.; Pandolfi, P.P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol., 2012, 13(5), 283-296.
23. [23] Stiles, B.L.; Kuralwalla-Martinez, C.; Guo, W. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol. Cell Biol., 2006, 26(7), 2772-2781.
24. [24] Gorbenko, O.; Panayotou, G.; Zhyvoloup, A.; Volkova, D.; Gout, I.; Filonenko, V. Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4. Mol. Cell Biochem., 2010, 337(1-2), 299-305.
25. [25] Tsuda, M.; Inoue-Narita, T.; Suzuki, A.; Itami, S.; Blumenberg, M.; Manabe, M. Induction of gene encoding FABP4 in Pten-null keratinocytes. FEBS Lett., 2009, 583(8), 1319-1322.
26. [26] Han, J.W.; Zhan, X.R.; Li, X.Y.; Xia, B.; Wang, Y.Y.; Zhang, J.; Li, B.X. Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World J. Gastroenterol., 2010, 16(48), 6111-6118.
27. [27] Wong, J.T.; Kim, P.T.; Peacock, J.W.; Yau, T.Y.; Mui, A.L.; Chung, S.W.; Sossi, V.; Doudet, D.; Green, D.; Ruth, T.J.; Parsons, R.; Verchere, C.B.; Ong, C.J. Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity. Diabetologia, 2007, 50(2), 395-403.
28. [28] Tong, Z.; Fan, Y.; Zhang, W.; Xu, J.; Cheng, J.; Ding, M.; Deng, H. Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling. Cell Res., 2009, 19(6), 710-719.
29. [29] Vellai, T.; McCulloch, D.; Gems, D.; Kovács, A.L. Effects of sex and insulin/insulin-like growth factor-1 signaling on performance in an associative learning paradigm in Caenorhabditis elegans. Genetics, 2006, 174(1), 309-316.
30. [30] Wang, L.; Liu, Y.; Yan, L.S.; Nguyen, K.T.; Schroer, S.A.; Suzuki, A.; Mak, T.W.; Gaisano, H.; Woo, M. Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes. Diabetes, 2010, 59(12), 3117-3126.
31. [31] Singh, G.; Chan, A.M. Post-translational modifications of PTEN and their potential therapeutic implications. Curr. Cancer Drug Targets, 2011, 11(5), 536-547.
32. [32] Gallwitz, B. Therapies for the treatment of type 2 diabetes mellitus based on incretin action. Minerva Endocrinol., 2006, 31(2), 133-147.
33. [33] Halperin, F.; Lopez, X.; Manning, R.; Kahn, C.R.; Kulkarni, R.N.; Goldfine, A.B. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes, 2012, 61(2), 301-309.
34. [34] Kowluru, A.; Kowluru, R.A. Phagocyte-like NADPH oxidase [Nox2] in cellular dysfunction in models of glucolipotoxicity and diabetes. Biochem. Pharmacol., 2014, 88(3), 275-283.
35. [35] Weaver, J.R.; Holman, T.R.; Imai, Y.; Jadhav, A.; Kenyon, V.; Maloney, D.J.; Nadler, J.L.; Rai, G.; Simeonov, A.; Taylor-Fishwick, D.A. Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Mol. Cell Endocrinol., 2012, 358(1), 88-95.
36. [36] Ma, Z.A. The role of peroxidation of mitochondrial membrane phospholipids in pancreatic β -cell failure. Curr. Diabetes Rev., 2012, 8(1), 69-75.
37. [37] Ma, Z.A.; Zhao, Z.; Turk, J. Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus. Exp. Diabetes Res., 2012, 2012, 703538.
38. [38] Rochette, L.; Zeller, M.; Cottin, Y.; Vergely, C. Diabetes, oxidative stress and therapeutic strategies. Biochim. Biophys. Acta, 2014, pii: S0304-4165(14) 00215-3.
39. [39] Acharya, J.D.; Ghaskadbi, S.S. Islets and their antioxidant defense. Islets, 2010, 2(4), 225-235.
40. [40] Yang, C.S.; Lee, J.S.; Rodgers, M.; Min, C.K.; Lee, J.Y.; Kim, H.J.; Lee, K.H.; Kim, C.J.; Oh, B.; Zandi, E.; Yue, Z.; Kramnik, I.; Liang, C.; Jung, J.U. Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe., 2012, 11(3), 264-276.
41. [41] Rocha, M.; Herance, R.; Rovira, S.; Hernández-Mijares, A.; Victor, V.M. Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect. Disord. Drug Targets, 2012, 12(2), 161-178.
42. [42] Blandino-Rosano, M.; Chen, A.Y.; Scheys, J.O.; Alejandro, E.U.; Gould, A.P.; Taranukha, T.; Elghazi, L.; Cras-Méneur, C.; Bernal-Mizrachi, E. mTORC1 signaling and regulation of pancreatic β-cell mass. Cell Cycle, 2012, 11(10), 1892-1902.
43. [43] Li, Z.Y.; Yang, Y.; Ming, M.; Liu, B. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem. Biophys. Res. Commun., 2011, 414(1), 5-8.
44. [44] Günther, T. The biochemical function of Mg²+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes. Res., 2010, 23(1), 5-18.
45. [45] Wang, X.; Hai, C.X. ROS acts as a double-edged sword in the pathogenesis of type 2 diabetes mellitus: is Nrf2 a potential target for the treatment? Mini Rev. Med. Chem., 2011, 11(12), 1082-1092.
46. [46] Tesoriere, L.; Attanzio, A.; Allegra, M.; Gentile, C.; Livrea, M.A. Indicaxanthin inhibits NADPH oxidase (NOX)-1 activation and NF-κB-dependent release of inflammatory mediators and prevents the increase of epithelial permeability in IL-1β-exposed Caco-2 cells. Br. J. Nutr., 2014, 111(3), 415-423.
47. [47] Li, Q.; Engelhardt, J.F. Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem., 2006, 281(3), 1495-1505.
48. [48] Chen, L.; Xu, B.; Liu, L.; Luo, Y.; Zhou, H.; Chen, W.; Shen, T.; Han, X.; Kontos, C.D.; Huang, S. Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free. Radic. Biol. Med., 2011, 50(5), 624-632.
49. [49] Xu, J.; Tian, W.; Ma, X.; Guo, J.; Shi, Q.; Jin, Y.; Xi, J.; Xu, Z. The molecular mechanism underlying morphine-induced Akt activation: roles of protein phosphatases and reactive oxygen species. Cell Biochem. Biophys., 2011, 61(2), 303-311.
50. [50] Yuan, H.; Lu, Y.; Huang, X.; He, Q.; Man, Y.; Zhou, Y.; Wang, S.; Li, J. Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1 cells. FEBS J., 2010, 277(24), 5061-5071.
51. [51] Lee, S.B.; Cho, E.S.; Yang, H.S.; Kim, H.; Um, H.D. Serum withdrawal kills U937 cells by inducing a positive mutual interaction between reactive oxygen species and phosphoinositide 3-kinase. Cell Signal, 2005, 17(2), 197-204.
52. [52] Kuehn, H.S.; Swindle, E.J.; Kim, M.S.; Beaven, M.A.; Metcalfe, D.D.; Gilfillan, A.M. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. J. Immunol., 2008, 181(11), 7706-7712.
53. [53] McGee, M.A.; Abdel-Rahman, A.A. Enhanced vascular PI3K/Akt-NOX signaling underlies the peripheral NMDAR-mediated pressor response in conscious rats. J. Cardiovasc. Pharmacol., 2014, 63(5), 395-405.
54. [54] Ngkelo, A.; Meja, K.; Yeadon, M.; Adcock, I.; Kirkham, P.A. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling. J. Inflamm. (Lond), 2012, 9(1), 1.
55. [55] Chatterjee, S.; Browning, E.A.; Hong, N.; DeBolt, K.; Sorokina, E.M.; Liu, W.; Birnbaum, M.J.; Fisher, A.B. Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am. J. Physiol. Heart Circ. Physiol., 2012, 302(1), H105-H114.
56. [56] Piro, S.; Anello, M.; Di Pietro, C.; Lizzio, M.N.; Patanè, G.; Rabuazzo, A.M.; Vigneri, R.; Purrello, M.; Purrello, F. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism, 2002, 51(10), 1340-1347.
57. [57] Yuan, H.; Zhang, X.; Huang, X.; Lu, Y.; Tang, W.; Man, Y.; Wang, S.; Xi, J.; Li, J. NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways. PLoS One, 2010, 5(12), e15726.
58. [58] Ohta, Y.; Kosaka, Y.; Kishimoto, N.; Wang, J.; Smith, S.B.; Honig, G.; Kim, H.; Gasa, R.M.; Neubauer, N.; Liou, A.; Tecott, L.H.; Deneris, E.S.; German, M.S. Convergence of the insulin and serotonin programs in the pancreatic β-cell. Diabetes, 2011, 60(12), 3208-3216.
59. [59] Chen, X.; Margolis, K.J.; Gershon, M.D.; Schwartz, G.J.; Sze, J.Y. Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake. PLoS One, 2012, 7(3), e32511.
60. [60] Sghendo, L.; Mifsud, J. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model. J. Pharm. Pharmacol., 2012, 64(3), 317-325.
61. [61] Wierup, N.; Gunnarsdóttir, A.; Ekblad, E.; Sundler, F. Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands. BMC Neurosci., 2007, 8, 51.
62. [62] Wierup, S.; Ikeda, M. Facilitation by endogenous acetylcholine and nitric oxide of luminal serotonin release from the guinea-pig colon. Eur. J. Pharmacol., 1998, 355(1), 51-55.
63. [63] Ohara-Imaizumi, M.; Kim, H.; Yoshida, M.; Fujiwara, T.; Aoyagi, K.; Toyofuku, Y.; Nakamichi, Y.; Nishiwaki, C.; Okamura, T.; Uchida, T.; Fujitani, Y.; Akagawa, K.; Kakei, M.; Watada, H.; German, M.S.; Nagamatsu, S. Serotonin regulates glucose-stimulated insulin secretion from pancreatic β cells during pregnancy. Proc. Natl. Acad. Sci. USA, 2013, 110(48), 19420-19425.
64. [64] Isaac, R.; Boura-Halfon, S.; Gurevitch, D.; Shainskaya, A.; Levkovitz, Y.; Zick, Y. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells. J. Biol. Chem., 2013, 288(8), 5682-5693.
65. [65] Sandyk, R. Serotonergic mechanisms in amyotrophic lateral sclerosis. Int. J. Neurosci., 2006, 116(7), 775-826.
66. [66] Leonard, B.E. Serotonin receptors--where are they going? Int. Clin. Psychopharmacol., 1994, 9 Suppl 1, 7-17.
67. [67] Cirillo, C.; Vanden Berghe, P.; Tack, J. Role of serotonin in gastrointestinal physiology and pathology. Minerva Endocrinol., 2011, 36(4), 311-324.
68. [68] Haub, S.; Ritze, Y.; Ladel, I.; Saum, K.; Hubert, A.; Spruss, A.; Trautwein, C.; Bischoff, S.C. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. J. Pharmacol. Exp. Ther., 2011, 339(3), 790-798.
69. [69] Beaulieu, J.M.; Gainetdinov, R.R.; Caron, M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol., 2009, 49, 327-347.
70. [70] Zamani, A.; Qu, Z. Serotonin activates angiogenic phosphorylation signaling in human endothelial cells. FEBS Lett., 2012, 586(16), 2360-2365.
71. [71] Beaulieu, J.M. A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J. Psychiatry. Neurosci., 2012, 37(1), 7-16.
72. [72] Kitagishi, Y.; Kobayashi, M.; Kikuta, K.; Matsuda, S. Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses. Depress Res. Treat., 2012, 2012, 752563.
73. [73] Jo, S.J.; Choi, S.J.; Yoon, S.Y.; Lee, J.Y.; Park, W.S.; Park, P.J.; Kim, K.H.; Eun, H.C.; Kwon, O. Valproic acid promotes human hair growth in in vitro culture model. J. Dermatol. Sci., 2013, 72(1), 16-24.
74. [74] Saunders, C.; Siuta, M.; Robertson, S.D.; Davis, A.R.; Sauer, J.; Matthies, H.J.; Gresch, P.J.; Airey, D.C.; Lindsley, C.W.; Schetz, J.A.; Niswender, K.D.; Veenstra-Vanderweele, J.M.; Galli, A. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function. Neurochem. Int., 2014, 73, 113-121.
75. [75] Tian, J.; Dang, H.; Chen, Z.; Guan, A.; Jin, Y.; Atkinson, M.A.; Kaufman, D.L. γ-Aminobutyric acid regulates both the survival and replication of human β-cells. Diabetes, 2013, 62(11), 3760-3765.
76. [76] Shi, Y.; Kanaani, J.; Menard-Rose, V.; Ma, Y.H.; Chang, P.Y.; Hanahan, D.; Tobin, A.; Grodsky, G.; Baekkeskov, S. Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion. Am. J. Physiol. Endocrinol. Metab., 2000, 279(3), E684-E694.
77. [77] Cabrera-Rode, E.; Perich, P.; Diaz-Horta, O.; Tiberti, C.; Molina, G.; Arranz, C.; Martin, J.M.; Licea, M.; De Leiva, A.D.; Puig-Domingo, M.; Dimario, U. Slowly progressing type 1 diabetes: persistence of islet cell autoantibodies is related to glibenclamide treatment, Autoimmunity, 2002, 35(7), 469-474.
78. [78] Walikonis, J.E.; Lennon, V.A. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin. Proc., 1998, 73(12), 1161-1166.
79. [79] Wang, Y.Y.; Legendre, P.; Huang, J.; Wang, W.; Wu, S.X.; Li, Y.Q. The effect of serotonin on GABA synthesis in cultured rat spinal dorsal horn neurons. J. Chem. Neuroanat., 2008, 36(3-4), 150-159.
80. [80] Bansal, P.; Wang, S.; Liu, S.; Xiang, Y.Y.; Lu, W.Y.; Wang, Q. GABA coordinates with insulin in regulating secretory function in pancreatic INS-1 β-cells. PLoS One, 2011, 6(10), e26225.
81. [81] Ligon, B.; Yang, J.; Morin, S.B.; Ruberti, M.F.; Steer, M.L. Regulation of pancreatic islet cell survival and replication by gamma-aminobutyric acid. Diabetologia, 2007, 50(4), 764-773.
82. [82] Rane, M.J.; Gozal, D.; Butt, W.; Gozal, E.; Pierce, W.M. Jr.; Guo, S.Z.; Wu, R.; Goldbart, A.D.; Thongboonkerd, V.; McLeish, K.R.; Klein, J.B. Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion. J. Immunol., 2005, 174(11), 7242-7249.
83. [83] Soltani, N.; Qiu, H.; Aleksic, M.; Glinka, Y.; Zhao, F.; Liu, R.; Li, Y.; Zhang, N.; Chakrabarti, R.; Ng, T.; Jin, T.; Zhang, H.; Lu, W.Y.; Feng, Z.P.; Prud'homme, G.J.; Wang, Q. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc. Natl. Acad. Sci. USA, 2011, 108(28), 11692-11697.
84. [84] Liu, R.; Zhang, L.; Lan, X.; Li, L.; Zhang, T.T.; Sun, J.H.; Du, G.H. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway. Neuroscience, 2011, 176, 408-419.
85. [85] Ramkumar, K.M.; Sekar, T.V.; Bhakkiyalakshmi, E.; Foygel, K.; Rajaguru, P.; Berger, F.; Paulmurugan, R. The impact of oxidative stress on islet transplantation and monitoring the graft survival by non-invasive imaging. Curr. Med. Chem., 2013, 20(9), 1127-1146.
86. [86] Kapsoritakis, A.N.; Rizos, C.D.; Delikoukos, S.; Kyriakou, D.; Koukoulis, G.K.; Potamianos, S.P. Retractile mesenteritis presenting with malabsorption syndrome. Successful treatment with oral pentoxifylline. J. Gastrointestin. Liver Dis., 2008, 17(1), 91-94.
87. [87] Rains, J.L.; Jain, S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med., 2011, 50(5), 567-575.
88. [88] Dal-Cim, T.; Molz, S.; Egea, J.; Parada, E.; Romero, A.; Budni, J.; Martín de Saavedra, M.D.; del Barrio, L.; Tasca, C.I.; López, M.G. Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway. Neurochem. Int., 2012, 61(3), 397-404.
89. [89] Hsu, J.T.; Kuo, C.J.; Chen, T.H.; Wang, F.; Lin, C.J.; Yeh, T.S.; Hwang, T.L.; Jan, Y.Y. Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J. Pineal. Res., 2012, 53(4), 410-416.
90. [90] Peuhkuri, K.; Sihvola, N.; Korpela, R. Dietary factors and fluctuating levels of melatonin. Food Nutr. Res., 2012, 56.
91. [91] Choi, E.M. Kaempferol protects MC3T3-E1 cells through antioxidant effect and regulation of mitochondrial function. Food Chem. Toxicol., 2011, 49(8), 1800-1805.
92. [92] Zhang, Y.; Liu, D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur. J. Pharmacol., 2011, 670(1), 325-332.
93. [93] López-Acosta, J.F.; Moreno-Amador, J.L.; Jiménez-Palomares, M.; Díaz-Marrero, A.R.; Cueto, M.; Perdomo, G.; Cózar-Castellano, I. Epoxypukalide induces proliferation and protects against cytokine-mediated apoptosis in primary cultures of pancreatic β-cells. PLoS One, 2013, 8(1), e52862.
94. [94] Bakirel, T.; Bakirel, U.; Keleş, O.U.; Ulgen, S.G.; Yardibi, H. In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits. J. Ethnopharmacol., 2008, 116(1), 64-73.
95. [95] Yoshida, H.; Okumura, N.; Kitagishi, Y.; Nishimura, Y.; Matsuda, S. Ethanol extract of Rosemary repressed PTEN expression in K562 culture cells. Int. J. Appl. Biol. Pharm. Technol., 2011, 2, 316-322.
96. [96] Peuhkuri, K.; Sihvola, N.; Korpela, R. Diet promotes sleep duration and quality. Nutr. Res., 2012, 32(5), 309-319.
97. [97] Waseem, T.; Duxbury, M.; Ashley, S.W.; Robinson, M.K. Ghrelin promotes intestinal epithelial cell proliferation through PI3K/Akt pathway and EGFR trans-activation both converging to ERK 1/2 phosphorylation. Peptides, 2014, 52, 113-121.
98. [98] Nakashima, N.; Sharma, P.M.; Imamura, T.; Bookstein, R.; Olefsky, J.M. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem., 2000, 275, 12889-12895.
99. [99] Lo, Y.T.; Tsao, C.J.; Liu, I.M.; Liou, S.S.; Cheng, J.T. Increase of PTEN gene expression in insulin resistance. Horm Metab. Res., 2004, 36(10), 662-666.
100. [100] Tang, X.; Powelka, A.M.; Soriano, N.A.; Czech, M.P.; Guilherme, A. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem., 2005, 280, 22523-22529.
101. [101] Silva, S.R.; Zaytseva, Y.Y.; Jackson, L.N.; Lee, E.Y.; Weiss, H.L.; Bowen, K.A.; Townsend, C.M. Jr.; Evers, B.M. The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON. Anticancer Res., 2011, 31(4), 1153-1160.
102. [102] Cai, J.; Yi, Z.; Lu, W.; Fang, Y.; Zhang, C. Crosstalk between 5-HT2cR and PTEN signaling pathway in atypical antipsychotic-induced metabolic syndrome and cognitive dysfunction. Med. Hypotheses, 2013, 80(4), 486-489.
103. [103] Liu, H.; Zang, C.; Emde, A.; Planas-Silva, M.D.; Rosche, M.; Kühnl, A.; Schulz, C.O.; Elstner, E.; Possinger, K.; Eucker, J. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur. J. Pharmacol., 2008, 591(1-3), 43-51.
104. [104] Crane, C.; Panner, A.; Pieper, R.O.; Arbiser, J.; Parsa, A.T. Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J. Immunother., 2009, 32(6), 585-592.
105. [105] Narayanan, N.K.; Nargi, D.; Randolph, C.; Narayanan, B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer., 2009, 125(1), 1-8.
106. [106] Fisman, E.Z.; Tenenbaum, A. A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease. Cardiovasc. Diabetol., 2009, 8, 38.